LL_Flex_970x90
    Advertisement
    For Immediate Sale - Cigarette Manufacturing & Tobacco Processing Equipment
    Advertisement

    More news this week

    Advertisement

    In Print

    Advertisement

    That Fleeting Scent

    The FDA’s proposed ban on menthol cigarettes and cigars remains highly controversial.

    Messy Market

    Ukraine’s anti-monopoly committee tries to break up a cartel it helped create.

    Genetic Scissors

    Demeetra AgBio offers tobacco companies a new tool to reduce nicotine levels.

    Clearing the Smoke

    James Murphy discusses the challenges and opportunities for tobacco harm reduction.

    Apples to Apples

    The comparison made between tobacco deaths and Covid-19 deaths does not hold water.

    The Test of Time

    Regulations and next-generation products are driving demand for quality-control instrumentation.

    Milestone Study

    A trial of BAT’s glo lends credibility to the harm reduction potential of the entire heated-tobacco category.

    The World is a Stage

    The TAI Group employs the principles of acting to improve interactions in corporate teams.

    Filling the Gaps

    The FDA gifted you a PMTA deficiency letter … what’s your strategy?

    Tobacco Reporter August 2021

    Tobacco Reporter’s August 2021 issue highlights Cas-CLOVER, a new genetic editing technology to help reduce nicotine levels in tobacco. If the U.S. Food and Drug Administration’s proposal to mandate ‘minimally addictive’ levels of the stimulant in tobacco products comes to fruition, cigarette companies will have to radically redesign their products. Cas-Clover will be yet another tool available to help them in that process.

    Coresta Secretary General Stephane Colard offers suggestions how the tobacco industry can demonstrate its responsible approach to a skeptical audience, and Reynold’s executive vice president of research and development, James Murphy, discusses the challenges and opportunities for tobacco harm reduction.

    Also in this issue: The makeover of the venerable Rizla brand, which traces its history to Napoleonic times, and an update on the crusade against menthol cigarettes, which is showing no signs of letting up.

    Advertisement

    Clive Bates


    A regular contributor to Tobacco Reporter, Clive Bates is the director of Counterfactual Consulting and the former director of Action on Smoking and Health (U.K.).

    In this section, we present a selection of his articles.

     

    Advertisement

    Fresh Thinking

    The World Health Organization and tobacco policy: a seven-point reform agenda

    The Endgame Revisited

    It is time to confront the fundamental confusion about the public health aims for tobacco and nicotine policy.

    KT_International_RevisedAd
    Advertisement

    Now available

    Advertisement
    Advertisement

    Also in TR

    One-Stop Shop

    ATD’s unique pedigree allows gives it a leg up in tackling the challenges of cigar manufacturing.

    Back to the Future

    KT&G continues to invest in its HnB segment while retaining its lead in traditional cigarettes.

    Heating Up

    Massive growth in Japan’s THP market has helped push cigarette sales to historic lows.

    The Way Forward

    The Global Forum on Nicotine debates harm reduction in Liverpool and online.

    A Solid Foundation

    The transition to less harmful nicotine products will succeed only if investors buy into the concept.

    Fearless Fighter

    How Mayiwepi Jiti became a successful grower in Zimbabwe’s male-dominated tobacco industry.

    Rooting for Science

    Participants in the In Focus: THR conference examined the state of harm reduction in a critical year.

    Beyond Volumes

    AOI believes there is opportunity for suppliers who can offer sustainably produced tobacco.

    tti
    Advertisement